A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

@article{Halfon2002APA,
  title={A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease},
  author={Philippe Halfon and Françoise Imbert-Bismut and Djamila Messous and Gilles Antoniotti and Didier Benchetrit and Philippe Cart-Lamy and Gilles Delaporte and Dani{\`e}le Doutheau and Th{\'e}o Klump and Michel Sala and Didier Thibaud and Elisabeth Trepo and Dominique Thabut and Robert P. Myers and Thierry Poynard},
  journal={Comparative Hepatology},
  year={2002},
  volume={1},
  pages={3 - 3}
}
BACKGROUND: Biochemical markers for liver fibrosis (FibroTest) and necroinflammatory features (ActiTest) are an alternative to liver biopsy in patients with chronic hepatitis C. Our aim was to assess the inter-laboratory variability of these tests, and their 6 components (gamma-glutamyl transpeptidase, alanine aminotransferase, alpha2-macroglobulin, haptoglobin, apolipoprotein A1, and total bilirubin) and to identify factors associated with this variability. RESULTS: Serum of 24 patients with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

Noninvasive biochemical markers of liver fibrosis.

Journal of gastrointestinal and liver diseases : JGLD • 2006
View 4 Excerpts
Highly Influenced

Simple biochemical parameters and a novel score correlate with absence of fibrosis in patients with nonalcoholic fatty liver disease

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Use of Fibrotest to predict liver fibrosis in hepatitis C : a replacement for liver biopsy ? [ abstract ]

L Adams, E Rossi, +4 authors G Jeffrey
Gastroenterology • 2002

Use of Fibrotest to predict liver fibrosis in hepatitis C: a replacement for liver biopsy

L Adams, E Rossi, +4 authors G Jeffrey
Gastroenterology • 2002
View 1 Excerpt

Calibration to achieve standardization in enzymology, example of ALT [abstract

A Myara, G Ferard, +5 authors D Dhumeaux
European Congress of Clinical Chemistry and Laboratory Medicine, Prague May 26– • 2001
View 2 Excerpts

Peg-Interferon alfa-2b in combination with ribavirin compared to interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C

MP Manns, JG McHutchison, +7 authors JK Albrecht
Lancet • 2001
View 1 Excerpt

User Guide

JL Hintze
2001

Appropriateness of Liver Biopsy

Canadian journal of gastroenterology = Journal canadien de gastroenterologie • 2000
View 3 Excerpts

Similar Papers

Loading similar papers…